BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23060037)

  • 21. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
    Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma.
    Chan AT; Zauber AG; Hsu M; Breazna A; Hunter DJ; Rosenstein RB; Eagle CJ; Hawk ET; Bertagnolli MM
    Gastroenterology; 2009 Jun; 136(7):2127-2136.e1. PubMed ID: 19233181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein and risk of colorectal adenoma according to celecoxib treatment.
    Chan AT; Sima CS; Zauber AG; Ridker PM; Hawk ET; Bertagnolli MM
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1172-80. PubMed ID: 21816845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.
    Kraus S; Hummler S; Toriola AT; Poole EM; Scherer D; Kotzmann J; Makar KW; Kazanov D; Galazan L; Naumov I; Coghill AE; Duggan D; Gigic B; Arber N; Ulrich CM
    Pharmacogenet Genomics; 2013 Aug; 23(8):428-437. PubMed ID: 23778325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial.
    Reid ME; Duffield-Lillico AJ; Sunga A; Fakih M; Alberts DS; Marshall JR
    Int J Cancer; 2006 Apr; 118(7):1777-81. PubMed ID: 16217756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence.
    Rahme E; Barkun AN; Toubouti Y; Bardou M
    Gastroenterology; 2003 Aug; 125(2):404-12. PubMed ID: 12891542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.
    Solomon SD; McMurray JJ; Pfeffer MA; Wittes J; Fowler R; Finn P; Anderson WF; Zauber A; Hawk E; Bertagnolli M;
    N Engl J Med; 2005 Mar; 352(11):1071-80. PubMed ID: 15713944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
    Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial.
    Grau MV; Baron JA; Sandler RS; Wallace K; Haile RW; Church TR; Beck GJ; Summers RW; Barry EL; Cole BF; Snover DC; Rothstein R; Mandel JS
    J Natl Cancer Inst; 2007 Jan; 99(2):129-36. PubMed ID: 17227996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
    Jaszewski R; Misra S; Tobi M; Ullah N; Naumoff JA; Kucuk O; Levi E; Axelrod BN; Patel BB; Majumdar AP
    World J Gastroenterol; 2008 Jul; 14(28):4492-8. PubMed ID: 18680228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics.
    Schatzkin A; Lanza E; Freedman LS; Tangrea J; Cooper MR; Marshall JR; Murphy PA; Selby JV; Shike M; Schade RR; Burt RW; Kikendall JW; Cahill J
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):375-83. PubMed ID: 9162304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention.
    Benamouzig R; Uzzan B; Martin A; Deyra J; Little J; Girard B; Chaussade S;
    Gut; 2010 May; 59(5):622-9. PubMed ID: 20427397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings.
    Benamouzig R; Yoon H; Little J; Martin A; Couturier D; Deyra J; Coste T; Chaussade S;
    Eur J Cancer Prev; 2001 Aug; 10(4):327-35. PubMed ID: 11535875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group.
    Bonithon-Kopp C; Kronborg O; Giacosa A; Räth U; Faivre J
    Lancet; 2000 Oct; 356(9238):1300-6. PubMed ID: 11073017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial.
    Passarelli MN; Barry EL; Rees JR; Mott LA; Ahnen DJ; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1262-1265. PubMed ID: 31263057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial.
    Bonelli L; Puntoni M; Gatteschi B; Massa P; Missale G; Munizzi F; Turbino L; Villanacci V; De Censi A; Bruzzi P
    J Gastroenterol; 2013 Jun; 48(6):698-705. PubMed ID: 23065023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.
    Benamouzig R; Uzzan B; Deyra J; Martin A; Girard B; Little J; Chaussade S;
    Gut; 2012 Feb; 61(2):255-61. PubMed ID: 21890814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and efficacy of celecoxib in children with familial adenomatous polyposis.
    Lynch PM; Ayers GD; Hawk E; Richmond E; Eagle C; Woloj M; Church J; Hasson H; Patterson S; Half E; Burke CA
    Am J Gastroenterol; 2010 Jun; 105(6):1437-43. PubMed ID: 20234350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.
    Meyskens FL; McLaren CE; Pelot D; Fujikawa-Brooks S; Carpenter PM; Hawk E; Kelloff G; Lawson MJ; Kidao J; McCracken J; Albers CG; Ahnen DJ; Turgeon DK; Goldschmid S; Lance P; Hagedorn CH; Gillen DL; Gerner EW
    Cancer Prev Res (Phila); 2008 Jun; 1(1):32-8. PubMed ID: 18841250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.
    Baron JA; Beach M; Mandel JS; van Stolk RU; Haile RW; Sandler RS; Rothstein R; Summers RW; Snover DC; Beck GJ; Bond JH; Greenberg ER
    N Engl J Med; 1999 Jan; 340(2):101-7. PubMed ID: 9887161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.